Vivani Medical
VANI
43 hedge funds and large institutions have $5.61M invested in Vivani Medical in 2026 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 5 closing their positions.
180% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 5
23% more funds holding
Funds holding: 35 → 43 (+8)
0.99% less ownership
Funds ownership: 7.62% → 6.63% (-0.99%)
18% less capital invested
Capital invested by funds: $6.84M → $5.61M (-$1.23M)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$414K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$174K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$85.3K |
| 4 |
AAG
Armstrong Advisory Group
Needham,
Massachusetts
|
+$81.3K |
| 5 |
BlackRock
New York
|
+$76.8K |
Top Sellers
VANI Hedge Fund Activity: Q1 2026 in Review
43 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q1 2026, worth a combined $5.61M — down 18% from $6.84M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new VANI positions and 5 closed out — a net gain of 9 holders — while 6 added to existing stakes and 9 trimmed.
The largest buyer was UBS Group, adding an estimated $414K. The largest seller was Tudor Investment Corp, cutting an estimated $613K.
- 43 institutional investors held Vivani Medical (VANI) as of Q1 2026, up from 35 in Q4 2025.
- Funds reported $5.61M of Vivani Medical stock for Q1 2026, down 18% quarter-over-quarter.
- 14 funds opened new Vivani Medical positions in Q1 2026 and 5 closed out, a net change of +9 holders.
- The largest Vivani Medical buyer in Q1 2026 was UBS Group, an estimated $414K added.
- The largest Vivani Medical seller in Q1 2026 was Tudor Investment Corp, an estimated $613K sold.
Based on aggregated 13F filings for Q1 2026.